Invest in

Biotech Breakthroughs

2.8%
3.0%
0.8%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
2.8%
3.0%
0.8%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
Open a Motif account to view and trade this basket of stocks:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
48.8% Research & Diagnostics 19.5%
13.7% Abbott Laboratories ABT 31.8%
8.2% 8xxxxx 8xxxxx 8xxxxxxxxx 8xxx 8xx 88.8%
8.1% 8xxxxxx 8xxxxxxxxxx 8xx 88.8%
4.6% 8xxxxxxxxx 8xxxxxxxxxx 8x 8xxxxxx 8xxxxx 8x 88.8%
3.6% 8xxxxxx 8xxxxxxxxxxx 8xx 8 88.8%
3.2% 8xxxx 8xxxxxxxxxx 8xxxxxxxxxxx 8xx 88.8%
2.9% 8xxxxxxxxxxxxx 8xxxxxxxxxxxx 8xxx 8xx 88.8%
2.1% 8xxxxxxxxxx 8xxx 8xx 88.8%
1.5% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
0.9% 8xxxxx 8xxxxxxxxxx 8xx 88.8%
37.6% Mature Biotechnology 7.0%
14.8% Amgen Inc. AMGN 13.7%
10.2% Gilead Sciences Inc. GILD 11.9%
6.7% 8xxxxx 8xxx 8xxx 88.8%
5.9% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
6.6% Other Biotech 70.6%
4.0% 8xxxx 8xx 8xxx 88.8%
1.4% 8xxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.1% 8xxxxxxx 8xx 8xxx 88.8%
4.0% Commercial Growth Biotech 27.2%
4.0% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.7% Early Commercial Biotech 19.1%
1.7% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.3% Development Stage Biotech 23.7%
1.3% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%

Quotes delayed 15 mins. Currently Jul 17, 2018 3:53:36 AM. Fields are marked with -- when data is unavailable.